Skip to main content

Westpac Banking Corp

SEC CIK
0000719245
Latest filing
Aug 12, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Westpac Banking Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q2 2026)
7,059
Value
$4.40M
% of portfolio
0.3%
Quarters held
22
Since Q1 2021
Holdings of REGN by Westpac Banking Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,059$4.40M0.3%−2,545−26.5%ReducedHolders
Q1 20269,604$7.42M0.5%+2,716+39.4%AddedHolders
Q4 20256,888$5.32M0.3%+6,073+745.2%AddedHolders
Q3 2025815$458.3K<0.1%00.0%UnchangedHolders
Q2 2025815$427.9K<0.1%−16−1.9%ReducedHolders
Q1 2025831$527.0K<0.1%−158−16.0%ReducedHolders
Q4 2024989$704.5K<0.1%00.0%UnchangedHolders
Q3 2024989$1.04M0.1%+66+7.2%AddedHolders
Q2 2024923$970.1K0.1%+80+9.5%AddedHolders
Q1 2024843$811.4K0.1%−18−2.1%ReducedHolders
Q4 2023861$756.2K0.1%+163+23.4%AddedHolders
Q3 2023698$574.4K<0.1%−2,828−80.2%ReducedHolders
Q2 20233,526$2.53M0.2%−12,248−77.6%ReducedHolders
Q1 202315,774$13.0M0.2%−3,096−16.4%ReducedHolders
Q4 202218,870$13.6M0.2%+9,646+104.6%AddedHolders
Q3 20229,224$6.35M0.1%−405−4.2%ReducedHolders
Q2 20229,629$5.69M0.1%−6,233−39.3%ReducedHolders
Q1 202215,862$11.1M0.1%−12,161−43.4%ReducedHolders
Q4 202128,023$17.7M0.2%+4,963+21.5%AddedHolders
Q3 202123,060$14.0M0.1%−9,447−29.1%ReducedHolders
Q2 202132,507$18.2M0.2%+7,613+30.6%AddedHolders
Q1 202124,894$11.8M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.